However, Chen et al. [56] suggested that NEC-1 does not alleviate cigarette-induced emphysema and airway inflammation, and hypothesized that in COPD, there may exist mechanisms of RIPK3 activation that are independent of RIPK1. This evidence concerns the gene RIPK1 and pulmonary emphysema.